Seeing Is Believing
Healthcare - Sector
ImmunoGen's activity chart (see below) currently has 127 price targets and 118 ratings on display.
Analysts average stock forecasts to be materialized ratio is 94.83% with an average time for these price targets to be met of 549.78 days.
Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 12-Feb-2024. First documented stock forecast 06-Aug-2012.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Feb-2024
$31
$-0.23 (-0.74%)
$31
2 years 8 months 12 days ago
(12-Feb-2024)
5/6 (83.33%)
$-0.23 (-0.74%)
121
Buy Since 04-Dec-2023
$31
$-0.23 (-0.74%)
$31
2 years 10 months 20 days ago
(04-Dec-2023)
4/4 (100%)
$1.78 (6.09%)
887
Buy Since 01-Dec-2023
$31
$-0.23 (-0.74%)
2 years 10 months 23 days ago
(01-Dec-2023)
2/2 (100%)
$1.68 (5.73%)
294
Buy Since 04-Mar-2019
$25
$-6.23 (-19.95%)
2 years 10 months 23 days ago
(01-Dec-2023)
2/3 (66.67%)
$-4.32 (-14.73%)
1387
Buy Since 16-Nov-2022
$31
$-0.23 (-0.74%)
$26
2 years 10 months 23 days ago
(01-Dec-2023)
4/4 (100%)
$1.68 (5.73%)
114
What is IMGN (ImmunoGen) average time for price targets to be met?
Which analyst most recently updated their price target on IMGN (ImmunoGen)?
Which analyst has the most public recommendations on IMGN (ImmunoGen)?
Which analyst is the currently most bullish on IMGN (ImmunoGen)?
Which analyst is the currently most reserved on IMGN (ImmunoGen)?